FDA
approval
· 2021-01-14
FDA Approved: BUPRENORPHINE HCL AND NALOXONE HCL — Supplemental Application (Amneal Pharmaceuticals LLC)
Summary
FDA approved a supplemental application for Amneal's generic buprenorphine HCl and naloxone HCl product.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for BUPRENORPHINE HCL AND NALOXONE HCL (BUPRENORPHINE AND NALOXONE)